NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
20.50
-1.34 (-6.14%)
At close: Jun 11, 2025, 4:00 PM
21.00
+0.50 (2.44%)
Pre-market: Jun 12, 2025, 7:12 AM EDT
NAMS Market Cap
NAMS has a market cap or net worth of $2.30 billion as of June 12, 2025. Its market cap has increased by 35.90% in one year.
Market Cap
2.30B
Enterprise Value
1.49B
1-Year Change
35.90%
Ranking
Category
Stock Price
$20.50
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $2.30B, an increase of 1,390.16%. That is a compound annual growth rate of 86.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2025 | 2.30B | -16.35% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 725.92B |
| Johnson & Johnson | 373.57B |
| Novo Nordisk | 353.21B |
| AbbVie | 338.27B |
| UnitedHealth Group | 281.72B |
| Abbott Laboratories | 235.37B |
| Novartis AG | 231.84B |
| AstraZeneca | 229.07B |